Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL GUT HEALTH SUPPLEMENTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL GUT HEALTH SUPPLEMENTS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMAPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 DEMAND AND SUPPLY-SIDE VARIABLES
2.2.8 TOP TO BOTTOM ANALYSIS
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL GUT HEALTH SUPPLEMENTS MARKET : RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 VALUE CHAIN ANALYSIS
5.2 SUPPLY CHAIN ANALYSIS
5.3 IMPORT-EXPORT ANALYSIS
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 BARGAINING POWER OF SUPPLIERS
5.4.2 BARGAINING POWER OF BUYERS/CONSUMERS
5.4.3 THREAT OF NEW ENTRANTS
5.4.4 THREAT OF SUBSTITUTE PRODUCTS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 RAW MATERIAL SOURCING ANALYSIS
5.6 OVERVIEW OF TECHNOLOGICAL INNOVATIONS
5.7 INDUSTRY TRENDS AND FUTURE PERSPECTIVE
5.8 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS
5.9 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS
6 IMPACT OF ECONOMIC SLOW DOWN ON MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON SUPPLY CHAIN
6.3 IMPACT ON SHIPMENT
6.4 IMPACT ON COMPANY’S STRATEGIC DECISIONS
7 REGULATORY FRAMEWORK AND GUIDELINES
8 BRAND OUTLOOK
8.1 COMPARATIVE BRAND ANALYSIS
8.2 PRODUCT VS BRAND OVERVIEW
9 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , BY PRODUCT TYPE, 2020-2029, (USD MILLION) , (KILO TONS)
(ASP, VALUE AND VOLUME WILL BE PROVIDED FOR ALL THE SEGMENTS)
9.1 OVERVIEW
9.2 PROBIOTICS
9.2.1 ASP
9.2.2 VALUE
9.2.3 VOLUME
9.2.4 PROBIOTICS, BY TYPE
9.2.4.1. BIFIDOBACTERIA
9.2.4.1.1. BIFIDOBACTERIUM ADOLESCENTIS
9.2.4.1.2. BIFIDOBACTERIUM ANIMALIS
9.2.4.1.3. BIFIDOBACTERIUM BIFIDUM
9.2.4.1.4. BIFIDOBACTERIUM BREVE
9.2.4.1.5. BIFIDOBACTERIUM LONGUM
9.2.4.2. LACTOBACILLUS
9.2.4.2.1. LACTOBACILLUS ACIDOPHILUS
9.2.4.2.2. LACTOBACILLUS RHAMNOSUS
9.2.4.2.3. LACTOBACILLUS CASEI
9.2.4.2.4. LACTOBACILLUS REUTERI
9.2.4.2.5. LACTOBACILLUS FERMENTUM
9.2.4.2.6. LACTOBACILLUS GASSERI
9.2.4.2.7. LACTOBACILLUS JOHNSONII
9.2.4.2.8. LACTOBACILLUS PARACAASEI
9.2.4.2.9. LACTOBACILLUS PLANTARUM
9.2.4.2.10. LACTOBACILLUS SALIVARIUS
9.2.4.2.11. LACTOBACILLUS THERMOPHILUS
9.2.4.2.12. LACTOBACILLUS BULGARICUS
9.2.4.2.13. OTHERS
9.2.4.3. STREPTOCOCCUS THERMOPHILUS
9.2.4.4. BACILLUS
9.2.4.5. ENTEROCOCCUS
9.2.4.6. PEDIOCOCCUS
9.2.4.7. PROPIONIBACTERIUM
9.2.4.8. OTHERS
9.3 PREBIOTICS
9.4 DIGESTIVE ENZYMES
9.5 POLYPHENOLS
9.6 OTHERS
10 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , BY CATEGORY, 2020-2029, (USD MILLION)
10.1 OVERVIEW
10.2 ORGANIC
10.3 CONVENTIONAL
11 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , BY FORM, 2020-2029, (USD MILLION)
11.1 OVERVIEW
11.2 TABLETS
11.3 POWDER
11.4 CAPSULES
11.5 GUMMIES
11.6 OTHERS (IF ANY)
12 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , BY END USER, 2020-2029, (USD MILLION)
12.1 OVERVIEW
12.2 ADULTS
12.2.1 MEN
12.2.2 WOMEN
12.3 SENIOR CITIZEN
12.4 PREGNANT WOMEN
12.5 OTHERS
12.5.1 INFANTS
12.5.2 CHILDREN
12.5.3 PETS
13 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , BY DISTRIBUTION CHANNEL, 2020-2029, (USD MILLION)
13.1 OVERVIEW
13.2 STORE BASED
13.2.1 HYPERMARKETS /SUPERMARKETS
13.2.2 CONVENIENCE STORES
13.2.3 PHARMACIES AND DRUG STORES
13.2.4 SPECIALTY STORES
13.2.5 DEPARTMENTAL STORES
13.3 NON STORE BASED
13.3.1 ONLINE RETAIL STORES
13.3.2 VENDING MACHINES
14 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
14.3 COMPANY SHARE ANALYSIS: EUROPE
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14.5 MERGERS & ACQUISITIONS
14.6 NEW PRODUCT DEVELOPMENT & APPROVALS
14.7 EXPANSIONS & PARTNERSHIP
14.8 REGULATORY CHANGES
15 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , BY GEOGRAPHY
OVERVIEW (ALL SEGMENTATION PROVIDED ABOVE IS REPRESNTED IN THIS CHAPTER BY COUNTRY)
15.1 NORTH AMERICA
15.1.1 U.S.
15.1.2 CANADA
15.1.3 MEXICO
15.2 EUROPE
15.2.1 GERMANY
15.2.2 U.K.
15.2.3 ITALY
15.2.4 FRANCE
15.2.5 SPAIN
15.2.6 SWITZERLAND
15.2.7 NETHERLANDS
15.2.8 BELGIUM
15.2.9 RUSSIA
15.2.10 DENMARK
15.2.11 SWEDEN
15.2.12 POLAND
15.2.13 TURKEY
15.2.14 REST OF EUROPE
15.3 ASIA-PACIFIC
15.3.1 JAPAN
15.3.2 CHINA
15.3.3 SOUTH KOREA
15.3.4 INDIA
15.3.5 AUSTRALIA
15.3.6 SINGAPORE
15.3.7 THAILAND
15.3.8 INDONESIA
15.3.9 MALAYSIA
15.3.10 PHILIPPINES
15.3.11 NEW ZEALAND
15.3.12 VIETNAM
15.3.13 REST OF ASIA-PACIFIC
15.4 SOUTH AMERICA
15.4.1 BRAZIL
15.4.2 ARGENTINA
15.4.3 REST OF SOUTH AMERICA
15.5 MIDDLE EAST AND AFRICA
15.5.1 SOUTH AFRICA
15.5.2 UAE
15.5.3 SAUDI ARABIA
15.5.4 OMAN
15.5.5 QATAR
15.5.6 KUWAIT
15.5.7 REST OF MIDDLE EAST AND AFRICA
16 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , SWOT & DBMR ANALYSIS
17 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , COMPANY PROFILE
17.1 CARGILL, INCORPORATED.
17.1.1 COMPANY OVERVIEW
17.1.2 REVENUE ANALYSIS
17.1.3 GEOGRAPHICAL PRESENCE
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 ADM
17.2.1 COMPANY OVERVIEW
17.2.2 REVENUE ANALYSIS
17.2.3 GEOGRAPHICAL PRESENCE
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 EVONIK INDUSTRIES AG
17.3.1 COMPANY OVERVIEW
17.3.2 REVENUE ANALYSIS
17.3.3 GEOGRAPHICAL PRESENCE
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENTS
17.4 BIOGAIA
17.4.1 COMPANY OVERVIEW
17.4.2 REVENUE ANALYSIS
17.4.3 GEOGRAPHICAL PRESENCE
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 CHR. HANSEN HOLDING A/S
17.5.1 COMPANY OVERVIEW
17.5.2 REVENUE ANALYSIS
17.5.3 GEOGRAPHICAL PRESENCE
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENTS
17.6 PROBI
17.6.1 COMPANY OVERVIEW
17.6.2 REVENUE ANALYSIS
17.6.3 GEOGRAPHICAL PRESENCE
17.6.4 PRODUCT PORTFOLIO
17.6.5 RECENT DEVELOPMENTS
17.7 YAKULT HONSHA CO.( GROUPE DANONE)
17.7.1 COMPANY OVERVIEW
17.7.2 REVENUE ANALYSIS
17.7.3 GEOGRAPHICAL PRESENCE
17.7.4 PRODUCT PORTFOLIO
17.7.5 RECENT DEVELOPMENTS
17.8 PROVEN PROBIOTICS. (CULTECH)
17.8.1 COMPANY OVERVIEW
17.8.2 REVENUE ANALYSIS
17.8.3 GEOGRAPHICAL PRESENCE
17.8.4 PRODUCT PORTFOLIO
17.8.5 RECENT DEVELOPMENTS
17.9 NATREN UK
17.9.1 COMPANY OVERVIEW
17.9.2 REVENUE ANALYSIS
17.9.3 GEOGRAPHICAL PRESENCE
17.9.4 PRODUCT PORTFOLIO
17.9.5 RECENT DEVELOPMENTS
17.1 UNIQUE BIOTECH
17.10.1 COMPANY OVERVIEW
17.10.2 REVENUE ANALYSIS
17.10.3 GEOGRAPHICAL PRESENCE
17.10.4 PRODUCT PORTFOLIO
17.10.5 RECENT DEVELOPMENTS
17.11 LALLEMAND INC
17.11.1 COMPANY OVERVIEW
17.11.2 REVENUE ANALYSIS
17.11.3 GEOGRAPHICAL PRESENCE
17.11.4 PRODUCT PORTFOLIO
17.11.5 RECENT DEVELOPMENTS
17.12 PFIZER INC.
17.12.1 COMPANY OVERVIEW
17.12.2 REVENUE ANALYSIS
17.12.3 GEOGRAPHICAL PRESENCE
17.12.4 PRODUCT PORTFOLIO
17.12.5 RECENT DEVELOPMENTS
17.13 AMWAY(ALTICOR)
17.13.1 COMPANY OVERVIEW
17.13.2 REVENUE ANALYSIS
17.13.3 GEOGRAPHICAL PRESENCE
17.13.4 PRODUCT PORTFOLIO
17.13.5 RECENT DEVELOPMENTS
17.14 NOVOZYMES A/S
17.14.1 COMPANY OVERVIEW
17.14.2 REVENUE ANALYSIS
17.14.3 GEOGRAPHICAL PRESENCE
17.14.4 PRODUCT PORTFOLIO
17.14.5 RECENT DEVELOPMENTS
17.15 WREN LABORATORIES(OPTIBAC PROBIOTICS)
17.15.1 COMPANY OVERVIEW
17.15.2 REVENUE ANALYSIS
17.15.3 GEOGRAPHICAL PRESENCE
17.15.4 PRODUCT PORTFOLIO
17.15.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
18 RELATED REPORTS
19 CONCLUSION
20 QUESTIONNAIRE
21 ABOUT DATA BRIDGE MARKET RESEARCH
